Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. Shandong Cancer Hospital , Shandong , China

Survival: 19.5 months
Toxicity Grade: 3
Treatments: Chemotherapy
Drugs: Pemetrexed
Country: China
City/State/Province: Shandong
Hospital: Shandong Cancer Hospital
Journal: Link
Date: 7/2015

This study involved 12 elderly primary central nervous system lymphoma patients. The median patient age was 73.9 years (range of 65-84 years) and 9 were male.

Patients received chemotherapy with pemetrexed.
The most severe toxicities were grade 3 anemia. Grade 2 leukopenia and vomiting were also reported.

The median overall survival was 19.5 months.

Correspondence: Dr. J. Yu; email:

E-mail to a Friend Email Physician More Information